Crospon logo

Home
About Us
Product Brochures
EndoFLIP® Technology

Clinical Applications

- Upper GI Surgery

- Bariatric Surgery

- Upper GI Imaging

- Cardiology

- Therapeutic Endoscopy

- Colorectal Imaging

Distributors
Newsroom
Events
Contact Us



 

 

Crospon wins Overall Medical Technology Excellence Award at the 2009 Irish Medical Device Association Excellence Awards

Irish Medical Device Association Award marks landmark year for Crospon

Monday 16th November 2009

Crospon, a medical device developer based in Galway is delighted to announce it has received the Overall Medical Technology Excellence Award and the Gold Award for Innovation and Research and Development at the Irish Medical Device Association Awards held on Thursday 12th of November at Dromoland Castle.

The Irish Medical Devices Association (IMDA) is an IBEC group that represents the medical technology sector in Ireland, and the IMDA Industry Excellence Awards are supported by Enterprise Ireland and the IDA.

rank Ryan CEO Enterprise Ireland, Mary Coughlan Tanaiste and Minister Enterprise Trade and Employment, John O’Dea CEO Crospon
Pictured left to right: Frank Ryan CEO Enterprise Ireland, Mary Coughlan Tanaiste and Minister Enterprise Trade and Employment, John O’Dea CEO Crospon

Crospon develops leading edge minimally invasive medical devices for monitoring, diagnosis and therapy in the gastroenterology area.

Commenting on the Award, John O’Dea, CEO, Crospon said, “We are in a critical phase of our development having recently established a US operation and launched the product into the European market. Recognition by the Irish Medical Device Association is a significant boost for Crospon and our EndoFLIP® system. Over the last number of years we have worked closely with IMDA and Enterprise Ireland and their assistance and advice has been vital to the development of Crospon and EndoFLIP® “.

2009 has been a landmark year for Crospon and its flagship gastroenterology product, EndoFLIP®. In June, Crospon announced that it had agreed a worldwide distribution deal for the EndoFLIP®. The agreement with Dutch company, Medical Measurement Systems, one of the world’s leading companies in the development and distribution of medical gastrodiagnostic systems resulted in the first customer shipments into Europe taking place in July.

The EndoFLIP® tool which is pending FDA approval was designed by Crospon to provide a more physiologically relevant diagnostic test for gastroesophageal reflux disease (GERD). Chronic GERD is a prevalent disorder reaching epidemic proportions worldwide that manifests itself as severe heartburn caused by stomach acid refluxing up into the oesophagus. Crospon’s development of the EndoFLIP® system was recognised with the 2009 European Gastroenterology Technology Implementation of the Year Award by Frost & Sullivan.

Earlier in the year, the Company also announced the establishment of a US operation in Carlsbad, California and that it had received CE Mark certification for the EndoFLIP® product in accordance with the European Medical Device Directive.

Adrian McHugh Dir. Engineering, Caroline Sherlock Dir. Operations, John O’Dea CEO, Mary Coughlan Tanaiste and Minister Enterprise Trade and Employment
Pictured left to right: Adrian McHugh Dir. Engineering, Caroline Sherlock Dir. Operations, John O’Dea CEO, Mary Coughlan Tanaiste and Minister Enterprise Trade and Employment

 

 
Newsroom Links
News Headlines
Upcoming Events
         
EndoFLIP logo   Crospon Inc. 701 Palomar Airport Rd, Carlsbad, CA 92011, USA. Phone: 1-855-CROSPON
Crospon Ireland. Galway Business Park, Dangan, Galway, Ireland Phone: +353-91-519880